Aptamer Group PLC

APTA

Company Profile

  • Business description

    Aptamer Group PLC provides Optimer binders for use in research, diagnostics and therapeutics. It strives to deliver transformational solutions that meet the needs of researchers and developers across the life sciences through the use of its proprietary Optimer technology. Its businesses: Aptamer Solutions for custom Optimer development, Aptamer Diagnostics for in-house and collaborative Optimer-based diagnostic development and Aptamer Therapeutics for the development of Optimer-based therapeutics. The Group represents a single operating segment being research and experimental development of biotechnology. It operates in United Kingdom, Europe, USA and other; Geographically earning maximum revenue from USA.

  • Contact

    Innovation Way
    Windmill House
    YorkYO10 5BR
    GBR

    T: +44 1904217404

    E: [email protected]

    https://www.aptamergroup.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    30 June 2025

    Employees

    34

Stocks News & Analysis

stocks

Is this ASX share a long-term buy?

Current operating conditions are challenging but over the long-term prospects are better.
stocks

Why Guzman and Reece's share reversals have a lot in common

Investors must weigh exciting growth stories against competitive dynamics and the price they are being asked to pay.
stocks

Going into earnings, is Nvidia stock a buy, a sell, or fairly valued?

Watching the data centre business and the debate around it, here’s what we think of Nvidia stock.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,477.3020.70-0.24%
CAC 408,143.9292.851.15%
DAX 4022,794.11383.841.71%
Dow JONES (US)43,412.50208.66-0.48%
FTSE 1008,731.4662.790.72%
HKSE23,787.93753.913.27%
NASDAQ19,089.0862.690.33%
Nikkei 22538,142.3795.42-0.25%
NZX 50 Index12,452.46145.191.18%
S&P 5005,957.191.940.03%
S&P/ASX 2008,240.7011.20-0.14%
SSE Composite Index3,380.2134.171.02%

Market Movers